AbbVie Inc $54.08

down -0.40


24/7/2014 04:00 PM  |  NYSE : ABBV  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get ABBV Trend Analysis - it has outperformed the S&P 500 by 6%

Partner Headlines

  1. #PreMarket Primer: Thursday, July 24: Facebook Proves Its Worth

    Benzinga
  2. FT: 25 More Firms May Seek Tax Breaks Overseas

    FoxBusiness
  3. Benzinga's Weekend M&A Chatter

    Benzinga
  4. AbbVie Clinches Shire Deal

    IBD
  5. Investors Focus On Earnings Rather Than Geopolitical Tensions

    Benzinga
  6. Will Congress Scuttle the AbbVie-Shire Merger?

    FoxBusiness
  7. AbbVie Buys Shire For $54 Billion

    IBD
  8. Stocks Futures Up On Q2 Reports; Abbvie-Shire, Google Positive

    IBD
  9. Benzinga's Top #PreMarket Losers

    Benzinga
  10. AbbVie to Acquire Shire for £24.44 in Cash and 0.8960 New AbbVie Shares

    Benzinga
  11. Markets Sell-Off After Malaysian Airline Crash In Ukraine

    Benzinga
  12. Treasury Urges Halt to Tax Inversion M&A 'Abuse'

    IBD
  13. J&J Earnings Beat Estimates, But Guidance Mixed

    IBD
  14. Bank Of America Boosts AbbVie PT On Increased Likelihood Of Deal

    Benzinga
  15. Irish Stocks Come To Prominence As Taxes Stay Low

    IBD
  16. AbbVie Near $54 Bil Shire Buy

    IBD
  17. Mylan, AbbVie News Shows Tax Inversion Boom Continues

    IBD
  18. Dow Sets New Intraday High; Citigroup Impresses With Earnings

    Benzinga
  19. Stocks On Pace For Second Gain; Kandi Keeps Soaring

    IBD
  20. Mylan Buying Abbott Generics Unit, Moving Abroad

    IBD
  21. Can Investors Profit From Friday's Rumors? Depends Who You Ask

    Benzinga
  22. Benzinga's Top #PreMarket Losers

    Benzinga
  23. US Stock Futures Surge; All Eyes On Citigroup Results

    Benzinga
  24. Benzinga's Weekend M&A Chatter

    Benzinga
  25. Walgreen Tax Inversion: Masking A Weak Business?

    YCharts
  26. Markets Close Higher Ahead Of Busy Earnings Season

    Benzinga
  27. Shire Shares Volatile Surrounding Speculation And Confirmation Of AbbVie ...

    Benzinga
  28. Stocks Trade Around Flat Line; Harman Clears Buy Point

    IBD
  29. Senators Ask Gilead To Explain Sovaldi Pricing

    IBD
  30. Benzinga's M&A Chatter for Wednesday July 9, 2014

    Benzinga
  31. Stocks Rebound From 2 Day Drop As The Fed Confirms The End Of QE Is Near

    Benzinga
  32. Deutsche Bank Analyst Talks Up Biogen On CNBC; Stock Responds Slightly

    Benzinga
  33. Celgene Drug Otezla Fails Trial, But Street Sanguine

    IBD
  34. #PreMarket Primer: Wednesday, July 9: Chinese CPI Cools In June

    Benzinga
  35. Benzinga's M&A Chatter for Tuesday July 8, 2014

    Benzinga
  36. AbbVie raises its bid for Shire

    IBD
  37. Memories Of March Return As Momentum Stocks Hit Hard

    Benzinga
  38. Major Indexes Cut More Losses; Alcoa Turns Up Ahead Of Earnings

    IBD
  39. Mid-Afternoon Market Update: The Fresh Market Drops Following Goldman Sachs ...

    Benzinga
  40. In Pursuit of Shire, AbbVie Eyes Lower Taxes in UK

    FoxBusiness
  41. The Fresh Market Drops Following Goldman Sachs Downgrade; Macquarie Infrastructure ...

    Benzinga
  42. AbbVie Raises Bid For Shire, But Both Stocks Fall

    IBD
  43. Markets Tumble; AbbVie Raises Offer For Shire

    Benzinga
  44. Morning Market Losers

    Benzinga
  45. Shire Offers Statement Following AbbVie Announcement, Says Board Will Meet ...

    Benzinga
  46. AbbVie Boosts Shire Offer For The 4th Time

    Benzinga
  47. IBD 50: Salix, Gilead Among Top Expected EPS Gainers

    IBD
  48. Merck, Gilead Lead Race To Eradicate Hepatitis C

    IBD
  49. Dow Trades Above 17,000 While S&P 500 Inches Closer To 2,000

    Benzinga
  50. Markets Little Changed Ahead Of 4th Of July Break

    Benzinga
Trading Center